Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1,001 - 10,000 - Monthly Reach
Unique listeners across all episodes (30 days)
5,001 - 25,000 - Active Followers
Loyal subscribers who consistently listen
5,001 - 15,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
David Southwell: CEO of Volastra Therapeutics
Feb 28, 2026
31m 26s
Stacy Lindborg: CEO of Imunon
Jan 26, 2026
33m 40s
Welcome to Season 8 of BioBoss
Dec 20, 2025
1m 22s
Michael Cloonan: CEO of Sionna Therapeutics
Nov 22, 2025
44m 22s
Erik van den Berg: CEO of Memo Therapeutics
Oct 27, 2025
30m 59s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 2/28/26 |  David Southwell: CEO of Volastra Therapeutics | David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers. | 31m 26s | ||||||
| 1/26/26 |  Stacy Lindborg: CEO of Imunon | Stacy Lindborg, CEO of Imunon, shares her insights about leadership in biopharma and how Imunon is working to develop medicines that harness the building blocks of life to work in harmony with the body's immune system. | 33m 40s | ||||||
| 12/20/25 |  Welcome to Season 8 of BioBoss | BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2026 | 1m 22s | ||||||
| 11/22/25 |  Michael Cloonan: CEO of Sionna Therapeutics | Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis. | 44m 22s | ||||||
| 10/27/25 |  Erik van den Berg: CEO of Memo Therapeutics | Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer. | 30m 59s | ||||||
| 9/29/25 |  Bruce Leuchter: CEO of Neurvati Neurosciences | Bruce Leuchter, CEO of Neurvati Neurosciences, shares his insights about leadership in biopharma and how Neurvati is working to advance drugs with the potential to improve the health and lives of people living with neurological and psychiatric disorders. | 46m 15s | ||||||
| 8/30/25 |  Todd Harris: CEO of Tyra Biosciences | Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology. | 29m 13s | ||||||
| 7/26/25 |  Eduardo Bravo: CEO of Citryll | Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases. | 31m 31s | ||||||
| 6/28/25 |  Abbas Kazimi: CEO of Nimbus Therapeutics | Abbas Kazimi, CEO of Nimbus Therapeutics, shares his insights about leadership in biopharma and how Nimbus is working to design and develop small molecule medicines capable of improving patients' lives. | 47m 13s | ||||||
| 5/24/25 |  Derek Adams: CEO of Stellular Bio | Derek Adams, CEO of Stellular Bio, shares his insights about leadership in biopharma and how Stellular Bio is working to expand the reach of regenerative medicine. | 42m 34s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/29/25 |  Geoffrey Dow: CEO of 60 Degrees Pharmaceuticals | Geoffrey Dow, CEO of 60 Degrees Pharmaceuticals, shares his insights about leadership in biopharma and how 60 Degrees Pharmaceuticals is working to develop vital medicines to treat and prevent infectious diseases. | 32m 43s | ||||||
| 3/29/25 |  Jorge Santos da Silva: Co-Founder and CEO of MoonLake Immunotherapeutics | Jorge Santos da Silva, co-founder and CEO of MoonLake Immunotherapeutics, shares his insights about leadership in biopharma and how MoonLake Immunotherapeutics is working to develop life changing therapies for people living with serious inflammatory diseases. | 40m 28s | ||||||
| 2/27/25 |  Vlad Vitoc - Founder and CEO of MAIA Biotechnology | Vlad Vitoc, founder and CEO of MAIA Biotechnology, shares his insights with BioBoss host John Simboli about leadership in biopharma and how MAIA is working to develop and deliver innovative medicines to improve and extend the lives of people living with cancer. | 35m 45s | ||||||
| 1/25/25 | What Leads the Leaders? Insights from BioBoss Season 1 | “What leads a leader?” As you listen to clips from BioBoss podcasts, you may hear remarkably consistent ideas about leadership, as shared by BioBoss guests, who reflect on their younger years and how those experiences shaped their desire, and ability to lead. | 7m 43s | ||||||
| 12/5/24 |  Welcome to Season 7 of BioBoss | BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2025 | 1m 40s | ||||||
| 10/31/24 |  Sam Clark: Founder and CEO of Terran Biosciences | Sam Clark, founder and CEO of Terran Biosciences, shares his insights with BioBoss host John Simboli about leadership in biopharma and how Terran is working to develop therapeutics and technologies for patients with neurological and psychiatric diseases. | 41m 12s | ||||||
| 9/28/24 |  Iain Kilty: CEO of Sitryx | Iain Kilty, CEO of Sitryx, shares his insights about leadership in biopharma and how Sitryx is working to alter immune cell metabolism to resolve disease | 41m 12s | ||||||
| 7/29/24 |  Steve Uden: Co-Founder and CEO of Rallybio | Steve Uden, co-founder and CEO of RallyBio, shares his insights about leadership in biopharma and how Rallybio is working to to profoundly change the odds for patients living with rare diseases. | 31m 54s | ||||||
| 5/21/24 |  Karine Rossignol: Co-Founder and CEO of Smart Immune | Karine Rossignol, co-founder and CEO of Smart Immune, shares her insights with BioBoss host John Simboli about leadership in biopharma and how Smart Immune is working to harness a patient's own thymus to re-arm the immune system against cancer and infection. | 36m 19s | ||||||
| 4/20/24 |  Erik Buntinx: Founder and CEO of ANeuroTech | Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients who suffer with depression | 49m 39s | ||||||
| 3/25/24 |  Helen Torley: CEO of Halozyme Therapeutics | Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes. | 39m 32s | ||||||
| 2/24/24 |  James Graham: CEO of Recce Pharmaceuticals | James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of antibiotic-resistant superbugs. | 21m 29s | ||||||
| 1/27/24 |  Mike Gaffney: CEO of Cellphire Therapeutics | Mike Gaffney, CEO of Cellphire Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Cellphire is working to save lives by bringing novel hemostatic products to patients in need. | 39m 39s | ||||||
| 12/16/23 |  David Baram: Founder and CEO of EmendoBio | David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease. | 36m 03s | ||||||
| 12/15/23 |  Welcome to Season 6 of BioBoss | BioBoss podcast host John Simboli reflects on Seasons 1-5 and invites listeners to Season 6 starting in January 2024 | 1m 07s | ||||||
Showing 25 of 95
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
9 placements across 9 markets.
Chart Positions
9 placements across 9 markets.